Evidence map›Paper›PMID 42704583›Full record

ArticleClinical rheumatology2026

Idiopathic granulomatous mastitis in the United Arab Emirates: a retrospective case series of clinical features, management, and outcomes.

Minat Allah Alhusami, Skylar Dsouza, Maya Himeidi, Noora Jatan, Amel Ginawi

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minat Allah AlhusamiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. MinatAllah.Alhusami@Students.MBRU.ac.ae.ORCID http://orcid.org/0009-0003-8043-1483
Skylar DsouzaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Maya HimeidiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Noora JatanCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Amel GinawiDepartment of Rheumatology, Mediclinic City Hospital, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdiopathic granulomatous mastitis (IGM) is a rare, chronic inflammatory breast disease that mimics infection and malignancy, with no standardized treatment approach.

methodsWe conducted a single center retrospective case series of 25 women with histopathologically confirmed IGM managed at a tertiary center in Dubai, UAE (June 2022-June 2025). Demographic, clinical, imaging, histopathological, treatment, and outcome data were analyzed. Remission was defined as complete clinical and radiological resolution sustained for at least 6 months after cessation of therapy. The median follow-up duration was 20 months.

resultsThe median age was 38 years; all patients were pre-or perimenopausal, and 92% (n = 23) had a history of breastfeeding. The most common presenting features were tenderness (92%, n = 23) and a palpable mass (88%, n = 22). Ultrasound frequently identified abscesses (60%, n = 15) and axillary lymphadenopathy (56%, n = 14), whereas mammography showed ductal dilatation (48%, n = 12) and solid masses (32%, n = 8). Histopathology demonstrated lobulocentric non-caseating granulomas in 72% (n = 18) and cystic neutrophilic granulomatous mastitis in 28% (n = 7) (n = 7), with overlapping abscess formation in 40% (n = 10). Medical therapy alone was used in 52% (n = 13) of patients and combined medical-surgical management in 48% (n = 12). Remission occurred in 69% (n = 9) of medically managed patients compared to 25% (n = 3) in the combined group.

conclusionIGM predominantly affected young, parous women and showed a heterogeneous clinical course. Medical management with corticosteroids, with or without disease-modifying anti-rheumatic drugs, appears to be associated with higher observed remission rates than combined surgical approaches. Early diagnosis and timely immunosuppressive therapy may reduce recurrence and avoid unnecessary surgery. Limitations include the small sample size, retrospective single-center design, and heterogeneity of treatment regimens. Key Points • Idiopathic granulomatous mastitis predominantly affected young, parous, premenopausal women with recent breastfeeding history. • Medical management with corticosteroids, with or without DMARDs, demonstrated higher observed remission rates than combined surgical approaches. • Surgical intervention was associated with greater complication burden, increased flares, and more chronic disease. • Early diagnosis and timely immunosuppressive therapy may improve outcomes while reducing unnecessary surgery.

Indexed as

Breast abscessCase seriesCorticosteroidsIdiopathic granulomatous mastitisInflammatory breast diseaseMedical managementMethotrexateRecurrenceSurgical management

Identifiers

PMID42704583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.